General Pathology - PowerPoint PPT Presentation

About This Presentation
Title:

General Pathology

Description:

Histogenetic Classification of Neoplasms Lymphomas & Leukemias (Hemoblastomas & Hemoblastoses) Jaroslava Du kov Inst. Pathol. ,1st Med. Faculty, Charles Univ. Prague – PowerPoint PPT presentation

Number of Views:153
Avg rating:3.0/5.0
Slides: 41
Provided by: Jarosl95
Category:

less

Transcript and Presenter's Notes

Title: General Pathology


1
General Pathology
  • Histogenetic Classification
  • of Neoplasms
  • Lymphomas Leukemias
  • (Hemoblastomas Hemoblastoses)

Jaroslava Dušková Inst. Pathol. ,1st Med.
Faculty, Charles Univ. Prague
2
Leukemia
  • def.
  • - diffuse neoplastic proliferation
  • of the hemopoietic marrow cell
    granulocytic
  • lymphocytic

3
Lymphoma
  • def.
  • malignant neoplasms of cells native to lymphoid
    tissue (lymphocytes, histiocytes) and their
    precursors and derivatives.
  • non Hodgkin (B,T) Hodgkin

4
NEOPLASIA classification
  • HISTOGENETIC (cell of origin)
  • mesenchymal
  • epithelial
  • neuroectodermal
  • mixed, teratoma
  • choriocarcinoma
  • mesotelioma

5
Main functions of the bone marrow and lymph nodes
  • hematopoetry
  • immune response
  • Hematopoetry
  • gr. haima- blood, poiétria - art of composition
    characterized by great beauty of expression

6
Lymphomas and Leukemias - clinical
symptomathology
  • LYMPHOMA
  • painless lymphadenomegaly
  • infiltrated organs
  • hepatosplenomegaly
  • bone marrow involvement ( leukemia)
  • LEUKEMIA
  • anaemia / fatigue
  • immunodepression infections, fever
  • haemorrhagic diathesis epistaxis, ecchymoses
  • bone pain
  • hepatosplenomegaly
  • CNS meningeal (ALL)

7
Pathology Genetics
  • Tumours of Haemopoietic and Lymphoid Tissues
  • WHO 2001

8
Principles of Classification
  • primarily according to lineage
  • myeloid
  • lymphoid
  • histiocytic/dendritic cell
  • mast cell
  • within each category
  • morphology
  • immunophenotype
  • genetic features
  • clinical syndromes

9
NEOPLASMS OF HEMATOPOIETIC AND LYMPHOID TISSUE
(WHO 2001, abbreviated)
  • Myeloid neoplasms
  • Chronic myeloproliferative disorders
  • Myeloproliferative / myelodysplastic diseases
  • Myelodysplastic syndromes
  • Acute myeloid leukemias
  • Lymphoid neoplasms
  • Precursor B and T cell neoplasms
  • Mature B cell neoplasms
  • Mature T and NK cell neoplasms
  • Hodgkin lymphoma
  • Histiocytic and dendritic cell neoplasms
  • Histiocytic sarcoma
  • Dendritic cell neoplasms
  • Mastocytosis

Most of them originate / may originate in
lymph nodes
10
Lymphomas and Leukemias - general macroscopy
features
  • LYMPH NODES
  • enlargement (painless)
  • BONE MARROW
  • pyoid (yellowish) or gray infiltration
  • activation of reserve zones
  • HEMOPOETRY HISTOHOMOLOGOUS ORGANS
  • enlargement
  • OTHER ORGANS
  • diffuse or tumorous infiltration

11
Lymphomas and Leukemias - general histology
features
  • LYMPH NODES
  • architecture partly / fully obscurred with the
    neoplastic population
  • subcapsullar sinus defunct
  • nodular / diffuse
  • transcapsullar spread
  • BONE MARROW
  • hypercellular
  • architecture partly / fully obscurred with the
    neoplastic population
  • haemopoetry activation in the formerly fatty
    (reserve) marrow

HISTOHOMOLOGOUS ORGANS colonised liver, spleen,
nodes
12
NEOPLASMS OF HEMATOPOIETIC AND LYMPHOID TISSUE
(WHO 2001, abbreviated)
  • Myeloid neoplasms
  • Chronic myeloproliferative disorders
  • Myeloproliferative / myelodysplastic diseases
  • Myelodysplastic syndromes
  • Acute myeloid leukemias
  • Lymphoid neoplasms
  • Precursor B and T cell neoplasms
  • Mature B cell neoplasms
  • Mature T and NK cell neoplasms
  • Hodgkin lymphoma
  • Histiocytic and dendritic cell neoplasms
  • Histiocytic sarcoma
  • Dendritic cell neoplasms
  • Mastocytosis

Most of them originate / may originate in
lymph nodes
13
Myeloid Diseases
  • Chronic myeloproliferative diseases CMPD
  • Myelodysplastic/myeloproliferative diseases
    MDS/MPD
  • Myelodysplastic syndromes - MDS
  • Acute myeloid leukaemias - AML

14
Chronic Myeloproliferative Diseases CMPD
  • def.
  • clonal proliferation of one or more of the
    myeloid lineages (granulocytic, erythroid,
    megakaryocytic)
  • hemopoietic stem cells in the bone marrow
  • hepatomegaly, splenomegaly
  • development into myelofibrosis or acute blast
    phase

15
Myeloid Diseases
  • Chronic myeloproliferative diseases CMPD
  • CML (Philadelphia chromosome t(9,22)(q34q11)
  • Chronic neutrophilic leukaemia
  • Chronic eosinophilic leukaemia
  • Polycythemia vera
  • Chronic idiopathic myelofibrosis
  • Essential thrombocythemia

16
Myeloid Diseases
  • Myelodysplastic/myeloproliferative diseases
    MDS/MPD
  • Chronic myelomonocytic leukaemia
  • Atypical chronic myeloid leukaemia
  • Juvenile myelomonocytic leukaemia
  • MDS/MPD - unclassifiable

17
Myelodysplastic syndromes - MDS
  • def.
  • bone marrow failure and dysplasia in one or more
    myeloid cell lineages
  • the number of blasts is in the blood or marrow lt
    20 (xAML)
  • development to acute leukaemia or death of bone
    marrow failure

18
Myeloid Diseases
  • Myelodysplastic syndromes - MDS
  • Refractory anaemia
  • Refractory anaemia with ringed sideroblasts
  • Refractory anaemia with multilineage dysplasia
  • Refractory anaemia with excess blasts
  • MDS associated with isolated del(5q) chromosome
    abnormality
  • MDS - unclassifiable

19
Myeloid Diseases
  • Acute myeloid leukaemias - AML clonal
    expansion of myeloid blasts in bone marrow blood
    or other tissue

20
Leukemia
  • Acute
  • morphology aplastic anemia
    agranulocytosis, thrombocytopenia
  • AML - adults
  • ALL - children

21
Myeloid Diseases
  • Acute myeloid leukaemias - AML
  • AML with recurrent cytogenetic abnormalities
  • AML with multilineage dysplasia
  • AML and MDS therapy- related
  • AML not otherwise categorised
  • 19 nosology units

22
NEOPLASMS OF HEMATOPOIETIC AND LYMPHOID TISSUE
(WHO 2001, abbreviated)
  • Myeloid neoplasms
  • Chronic myeloproliferative disorders
  • Myeloproliferative / myelodysplastic diseases
  • Myelodysplastic syndromes
  • Acute myeloid leukemias
  • Lymphoid neoplasms
  • Precursor B and T cell neoplasms
  • Mature B cell neoplasms
  • Mature T and NK cell neoplasms
  • Hodgkin lymphoma
  • Histiocytic and dendritic cell neoplasms
  • Histiocytic sarcoma
  • Dendritic cell neoplasms
  • Mastocytosis

Most of them originate / may originate in
lymph nodes
23
Lymphoma
  • def.
  • malignant neoplasms of cells native to lymphoid
    tissue (lymphocytes, histiocytes) and their
    precursors and derivatives.
  • non Hodgkin (B,T) Hodgkin

24
Lymphoid Neoplasms
  • B cell (lymphomas leukaemias)
  • T and NK cell --
  • Hodgkin lymphomas

25
Lymphoid Neoplasms
  • B cell lymphomas leukaemias
  • (17 nosology units in 2001 WHO classif.)
  • Precursor B-cell neoplasm
  • Mature B-cell neoplasms (85 nH ML)
  • B-cell proliferations of uncertain malignant
    potential

26
Small Lymphocytic Lymhpoma (SLL) /
Chronic Lymhocytic Leukemia (CLL)
  • Small B-lymphocytes, proliferating cells
    (prolymphocyte, paraimmunoblast)
  • peripheral blood lymphocytes gt10x109/ l,
  • bone marrow lymphocytic infiltration
  • splenomegaly, hepatomegaly,
    lymphadenopathy
  • immunodeficiency, bleeding, disordered healing
  • Clinical behaviour
  • INDOLENT
  • leukemisation common
  • occasional transformation to aggressive
    lymphoma / leukemia
  • Dg Morphology confusing - immunophenotyping
    necessary
  • CD23, CD5, cyclin D1

27
Leukemia
  • Chronic
  • morphology bone marrow infiltration
    splenomegaly
  • hepatomegaly
  • enlarged lymph nodes
  • clinic may remain silent for a long time
  • CML related to myeloproliferative disorders
  • CLL close to nH ML (95B)
  • Hairy cell leukemia tricholeukemia
  • small B lymphoid cells

28
Lymphoplasmocytic lymphoma LPL /Waldenström
macroglobulinemia
  • small B lymhocytes lymphoma
  • bone marrow, LN, spleen
  • older adults
  • monoclonal IgM serum paraprotein
  • hyperviscosity symptoms

29
Burkitts Lymphoma
  • highly malignant small B cell lymphoma EBV
    (DNA) related
  • endemic in Africa, sporadic elsewhere
  • high mitotic rate
  • starry sky appearance (due to non neoplastic
    macrophages admixture)

30
Lymphoid Neoplasms
  • B cell (lymphomas leukaemias)
  • T and NK cell --
  • Hodgkin lymphomas

31
Lymphoid Neoplasms
  • T and NK cell lymphomas leukaemias
  • (16 nosology units in 2001 WHO classif.)
  • Precursor T-cell neoplasm
  • Mature T-cell neoplasms (EB virus HTLV-1)
  • T-cell proliferations of uncertain malignant
    potential

32
Mycosis Fungoides and Sezary Syndrome
  • Def.
  • MF mature T- cell lymphoma presenting in the
    skin with patches/plaques and characterized by
    epidermal and dermal infiltration of small to
    medium size T-cells with cerebriform nuclei
  • SS generalized mature T- cell lymphoma
    characterized by the presence of erythroderma ,
    lymphadenopathy and T-cells with cerebriform
    nuclei aggresive form of MF

33
Mycosis fungoides and Sezary Syndrome
  • adults MF 21
  • years lasting course
  • trunk erruptions
  • rarely generalization

34
Lymphoid Neoplasms
  • B cell (lymphomas leukaemias)
  • T and NK cell --
  • Hodgkin lymphomas

35
Lymphogranuloma Malignum Hodgkin
  • def.
  • malignant lymphoma containing diagnostic RS or
    Hodgkin tumorous cells in a rich cellular
    background

36
Lymphoid Neoplasms WHO 2001
  • Hodgkin lymphomas HL
  • Nodular lymphocyte predominant HL
  • Classical HL
  • Nodular sclerosis classical HL
  • Lymphocyte-rich classical HL
  • Mixed cellularity classical HL
  • Lymphocyte-depleted classical HL

37
Classical HL (CHL)
  • 85 of HL
  • Nodular sclerosis CHL (NSHL)
  • Most frequent, young adults
  • Very good prognosis with treatment
  • Lymphocyte-rich CHL (LRCHL)
  • Rare
  • Very good prognosis with treatment
  • Mixed cellularity CHL (MCHL)
  • Frequent, adults
  • Medium prognosis
  • Lymphocyte depleted CHL (LDHL)
  • Very rare, immunocompromised patients
  • Poor prognosis

38
Nodular Lymphocyte Predominant HL
15 of HL B-lymphoma Differential diagnosis
may be very difficult Highly atypical
CD30-/CD15-/CD20/CD45 L/H cells popcorn
cells Reactive cells Lymphocytes,
histiocytes, plasma cells, no eosinophils Nodular
growth No fibrosis Very good prognosis with
treatment even in relapsing disease
39
NEOPLASMS OF HEMATOPOIETIC AND LYMPHOID TISSUE
(WHO 2001, abbreviated)
  • Myeloid neoplasms
  • Chronic myeloproliferative disorders
  • Myeloproliferative / myelodysplastic diseases
  • Myelodysplastic syndromes
  • Acute myeloid leukemias
  • Lymphoid neoplasms
  • Precursor B and T cell neoplasms
  • Mature B cell neoplasms
  • Mature T and NK cell neoplasms
  • Hodgkin lymphoma
  • Histiocytic and dendritic cell neoplasms
  • Histiocytic sarcoma
  • Dendritic cell neoplasms
  • Mastocytosis

Most of them originate / may originate in
lymph nodes
40
Histiocytic and Dendritic Cell Neoplasms
  • Macrophage/histiocytic neoplasm (CD68, CD 1)
  • Langerhans cells
  • m. Hand Schüller- Christian HSCH triad calva
    defects, diab.insip., exophtalmos
  • eosinophilic granuloma (bone)
  • m. Letterer Sive (skin , hepatosplenomegaly,
    lymph nodes)
  • Dendritic cell neoplasms
  • Mastocytosis
Write a Comment
User Comments (0)
About PowerShow.com